Literature DB >> 2308185

American Thyroid Association guidelines for use of laboratory tests in thyroid disorders.

M I Surks1, I J Chopra, C N Mariash, J T Nicoloff, D H Solomon.   

Abstract

Selection of appropriate laboratory determinations will enable the clinician to diagnose thyroid dysfunction readily in the majority of patients. At the present time, estimation of free thyroxine and a "sensitive" thyrotropin assay are recommended as the principal laboratory tests for thyroid disease. A decrease in serum free thyroxine estimate and a raised level of serum thyrotropin confirm the diagnosis of hypothyroidism caused by thyroid gland failure. An increase in free thyroxine estimate combined with a serum sensitive thyrotropin level suppressed to less than 0.1 mU/L establishes the diagnosis of thyrotoxicosis. In sick patients, a normal or raised serum free thyroxine estimate together with a normal level of serum thyrotropin suggests that the patient has neither hypothyroidism nor thyrotoxicosis. Patients with severe illnesses, generally in the intensive care unit, and those treated with certain drugs, as well as individuals with unusual thyroid disorders, may present with confusing laboratory findings. An understanding of the regulation of the thyroid hormone system and/or judicious consultation with an endocrinologist should enable the clinician to diagnose thyroid disease, if present, in such patients.

Entities:  

Mesh:

Year:  1990        PMID: 2308185

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  36 in total

1.  Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia.

Authors:  Nancy A Hodgson; Laura N Gitlin; Laraine Winter; Kathleen Czekanski
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

2.  Thyroid function tests and hypothyroidism.

Authors:  Anthony D Toft; Geoffrey J Beckett
Journal:  BMJ       Date:  2003-02-08

Review 3.  United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies.

Authors:  Woondong Jeong; James H Doroshow; Shivaani Kummar
Journal:  Curr Probl Cancer       Date:  2013 May-Jun       Impact factor: 3.187

4.  Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  G M Calvert; M H Sweeney; J Deddens; D K Wall
Journal:  Occup Environ Med       Date:  1999-04       Impact factor: 4.402

5.  Subclinical hypothyroidism revisited. When is not enough really not enough?

Authors:  D R Goldmann
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

6.  The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects.

Authors:  Da Young Lee; Jae Hwan Jee; Ji Eun Jun; Tae Hyuk Kim; Sang-Man Jin; Kyu Yeon Hur; Sun Wook Kim; Jae Hoon Chung; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

7.  Decoding laboratory test names: a major challenge to appropriate patient care.

Authors:  Elissa Passiment; James L Meisel; John Fontanesi; George Fritsma; Samir Aleryani; Marisa Marques
Journal:  J Gen Intern Med       Date:  2012-11-29       Impact factor: 5.128

8.  TSH Comparison Between Chemiluminescence (Architect) and Electrochemiluminescence (Cobas) Immunoassays: An Indian Population Perspective.

Authors:  Rajarshi Sarkar
Journal:  Indian J Clin Biochem       Date:  2013-05-26

9.  Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.

Authors:  P De Whalley
Journal:  Br J Gen Pract       Date:  1995-02       Impact factor: 5.386

Review 10.  [Autoimmune functional disorders of the thyroid during interferon-beta-1b treatment in patients with multiple sclerosis. Case report and literature review].

Authors:  C Lange-Asschenfeldt; S Boor; G J Kahaly; F Thömke
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.